The Randomized Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) observational follow-up study: benefits of RAS blockade with olmesartan treatment are sustained after study discontinuation.

J Am Heart Assoc · 2014 · PMC4187490 · PMID 24772521

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Congestive heart failure (12 versus 3; P =0.027) was more common in the former placebo group and nonfatal strokes (18 versus 7; P =0.069) showed a trend towards more events.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.